The present findings demonstrate that tectorigenin attenuated insulin resistance (IR) associated with endothelial dysfunction through inhibiting ROS-related inflammation in endothelium cells, as well as facilitating insulin IRS-1/PI3K/Akt/eNOS signaling pathway. The gene discussed is INS; the disease is endothelial dysfunction.